Mr. French currently serves as Chairman of the Company’s Board of Directors. Mr. French is a founder and Managing Director of Santé Ventures, an investor in early stage life science and healthcare companies. Mr. French is the past President and Chief Executive Officer of the Ascension Health system and creator of the Ascension Health Ventures corporate fund. Immediately prior to founding Santé Ventures, Mr. French served as a healthcare Venture Partner with Austin Ventures. With more than 25 years of experience in the field of healthcare and a vast network of relationships, he is one of the most respected and recognized leaders in the industry. He is known as an innovative and creative leader, a successful risk taker, and superb developer of people and organizations. Mr. French serves on the board of Herman Miller (MLHR) and is a prior board member of Ascension Health, Catholic Healthcare West and the Catholic Healthcare Association. Mr. French holds a B.S. Degree from Trevecca Nazarene College in Nashville, Tennessee and a Masters in Hospital and Health Services Administration from Xavier University in Cincinnati, Ohio.
Mr. Schmitz is an Investment Director at Endeavour Vision, focusing on medical technology and digital health investments. Mr. Schmitz brings nearly two decades of business and strategy experience in both medical device and high-technology companies. From 2005 to 2014, he helped Biosensors International Group develop its interventional cardiology business, from less than $5 million in annual revenues to more than $300 million. In various positions, he played a key role in establishing and building the company’s presence across Europe and Asia, most recently serving as vice president of business development, based in Switzerland. Prior to Biosensors, he spent three years with LogiSpring, the corporate venture fund of the TNT Post Group, advising on investments enabling supply chain and industrial automation applications. He also previously worked for MicroStrategy, a leading provider of business intelligence software, helping clients in the financial services industry develop and deploy complex risk management and financial information systems. Alex began his career as a management consultant with McKinsey & Company, where in addition to serving clients in the aerospace and telecommunications industries, he also spent a year with the McKinsey Global Institute analysing regional differences in productivity growth, based in Washington, D.C. and Seoul. He earned an MBA from INSEAD and a BSFS, magna cum laude, from Georgetown University’s School of Foreign Service, where he was a Krogh Scholar and a member of Phi Beta Kappa.
Dr. Hoare is the President and Chief Executive Officer of EndoStim. Dr. Hoare has extensive experience in the neuromodulation industry, including spinal cord, deep brain and vagus nerve stimulation. He was previously the President, Neuromodulation at LivaNova (formed by the merger of Cyberonics and Sorin Group). At Cyberonics, Dr. Hoare was the Chief Operating Officer. Prior to this he held numerous leadership positions at St Jude Medical including President, Neuromodulation Division. Early in his career Dr. Hoare was a consultant with McKinsey & Co., a premiere management consulting firm. He holds a Ph.D. in Physics from Harvard University where he was a Fulbright Scholar. He completed his undergraduate studies at Monash University in Melbourne, Australia.